Hemophilia B Leyden
- 1 April 1982
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 306 (13) , 788-790
- https://doi.org/10.1056/nejm198204013061306
Abstract
HEMOPHILIA B is a hemorrhagic disease inherited in a sex-linked recessive pattern.1 The clinical severity of hemophilia B, which is dependent on factor IX coagulant activity (IX:C), varies between kindreds but not within kindreds and is constant throughout the life of affected persons. Factor IX antigen levels (IX:Ag) in hemophila B, determined by immunologic assays, also vary between and not within kindreds but do not always correlate with IX:C levels. For example, some patients with IX:C levels below 1 per cent of normal (i.e., those with severe hemophilia B) have normal IX:Ag levels, which indicates that the factor IX molecules . . .Keywords
This publication has 8 references indexed in Scilit:
- Hereditary angio-oedema: treatment with danazol.British Journal of Dermatology, 1979
- Oral contraception and the detection of carriers in haemophilia BThrombosis Research, 1978
- Treatment of Hereditary Angioedema with DanazolNew England Journal of Medicine, 1976
- Genetic variants of hemophilia B: detection by means of a specific PTC inhibitorJournal of Clinical Investigation, 1968
- Detection of the Carrier State in Hereditary Coagulation Disorders IThrombosis and Haemostasis, 1968
- HÆMOPHILIA BM: A NEW TYPE OF FACTOR-IX DEFICIENCYThe Lancet, 1967
- INVESTIGATION OF A HÆMORRHAGIC DISEASE DUE TO BETA‐PROTHROMBOPLASTIN DEFICIENCY COMPLICATED BY A SPECIFIC INHIBITOR OF THROMBOPLASTIN FORMATIONAustralasian Annals of Medicine, 1956
- Christmas DiseaseBMJ, 1952